P J Smak Gregoor
Overview
Explore the profile of P J Smak Gregoor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weimar W, van Riemsdijk I, Smak Gregoor P, van Gelder T
Transplant Proc
. 2001 Dec;
33(7-8):3176-7.
PMID: 11750363
No abstract available.
2.
Smak Gregoor P, Zietse R, van Saase J, Op de Hoek C, Ijzermans J, Lavrijssen A, et al.
Clin Transplant
. 2001 Dec;
15(6):397-401.
PMID: 11737116
Patients returning to haemodialysis or peritoneal dialysis after a failed kidney transplantation sometimes have a renal allograft left in situ for some urine production. Low-dose immunosuppressive medication is often continued...
3.
van Besouw N, van der Mast B, de Kuiper P, Smak Gregoor P, Vaessen L, Ijzermans J, et al.
Transplant Proc
. 2001 May;
33(3):2239-40.
PMID: 11377514
No abstract available.
4.
Smak Gregoor P, van Gelder T, van Besouw N, van der Mast B, Hesse C, Ijzermans J, et al.
Transpl Int
. 2000 Dec;
13 Suppl 1:S333-5.
PMID: 11112026
Twenty-seven stable kidney transplant recipients treated with cyclosporine and prednisone were converted to mycophenolate mofetil (MMF) and prednisone 1 year after transplantation. After conversion the patients were treated with a...
5.
Smak Gregoor P, van Gelder T, Weimar W
Neth J Med
. 2000 Dec;
57(6):233-46.
PMID: 11099793
Mycophenolate mofetil is a new immunosuppressive drug, exhibiting its effect through inhibition of proliferation of T- and B-lymphocytes. Superior efficacy of mycophenolate mofetil compared to azathioprine, in combination with cyclosporine...
6.
van Gelder T, Smak Gregoor P, Weimar W
Ther Drug Monit
. 2000 Oct;
22(5):639.
PMID: 11034275
No abstract available.
7.
Smak Gregoor P, van Gelder T, van Besouw N, van der Mast B, Ijzermans J, Weimar W
Transplantation
. 2000 Aug;
70(1):143-8.
PMID: 10919591
Background: The introduction of cyclosporine (CsA) in kidney transplantation has improved early graft survival. However, its long-term use is associated with impairment of renal function and increased cardiovascular risk factors....
8.
van Besouw N, van der Mast B, de Kuiper P, Smak Gregoor P, Vaessen L, Ijzermans J, et al.
Transplantation
. 2000 Aug;
70(1):136-43.
PMID: 10919590
Background: To reduce the side effects of long-term immunosuppressive therapy, stable renal transplant patients were routinely converted from cyclosporine to either azathioprine or mycophenolate mofetil. Thereafter, the azathioprine and mycophenolate...
9.
van Besouw N, van der Mast B, Smak Gregoor P, Hesse C, Ijzermans J, van Gelder T, et al.
Nephrol Dial Transplant
. 1999 Oct;
14(11):2710-3.
PMID: 10534517
Background: Both mycophenolate mofetil (MMF) and azathioprine (AZA) are immunosuppressive drugs that inhibit purine synthesis. In theory, MMF selectively inhibits lymphocyte proliferation, while AZA has well-known effects on red blood...
10.
Smak Gregoor P, van Gelder T, Hesse C, van der Mast B, van Besouw N, Weimar W
Nephrol Dial Transplant
. 1999 Apr;
14(3):706-8.
PMID: 10193823
Background: Combining cyclosporin (CsA) and prednisone with mycophenolate mofetil (MMF) results in a significant reduction in the rate of biopsy-proven acute rejection after kidney transplantation. This is achieved with a...